The gray underbelly is the section with the sharkskin material. The inset shows its microscopic ridges. The first XB-1 flights were initially subsonic flights to test the material’s adhesive ...

Boom’s recent supersonic tests included an experimental sharkskin-like material that makes the aircraft smoother and therefore more efficient. Developed by Micro Tau in Australia, the riblet-skinned ...

Boom’s recent supersonic tests included an experimental sharkskin-like material that makes the aircraft smoother and therefore more efficient. Developed by Micro Tau in Australia, the riblet ...

Credit: Lufthansa Technik In the early 1970s, German biologist Wolf-Ernst Reif was studying sharkskin fossils when newly available scanning electron microscopes enabled him to discover small ...

A third of all Joann fabric and craft stores, including 12 in New York, will be closed by May. More than 500 stores remain but are scheduled to close by the end of May, as previously announced in ...

(CNN) – Nearly one-third of Joann Fabric and Craft store locations will close this week, and the remaining stores will shut down next month. The company filed for bankruptcy last January.

April 16, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced its plans to acquire Fabric Genomics, a pioneer in ...

“It is no use asking for the impossible, such as, say, the exact wiring diagram for a cubic millimeter of brain tissue and the way all its neurons are firing,” Crick wrote in Scientific America ...

Joann fabric and craft retailer is closing all its stores after filing for bankruptcy. Nine Florida stores closed on April 28th, with others closing earlier in the month. All of Joann's remaining ...

Fabric’s data agents are designed to be built and tested outside the Azure AI Foundry. You can use them to explore your data conversationally, as an alternative approach to traditional analytics ...

For decades, the United States has led the world in biotech and pharmaceutical innovation. But our dominance is now at risk: not from external sabotage, but from our own regulatory sclerosis.